Euda Health Holdings Stock Analysis
EUDA Stock | 3.16 0.09 2.77% |
EUDA Health Holdings is undervalued with Real Value of 3.8 and Target Price of 6.0. The main objective of EUDA Health stock analysis is to determine its intrinsic value, which is an estimate of what EUDA Health Holdings is worth, separate from its market price. There are two main types of EUDA Health's stock analysis: fundamental analysis and technical analysis.
The EUDA Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and EUDA Health's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EUDA Health Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. EUDA Stock Analysis Notes
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.54. EUDA Health Holdings had not issued any dividends in recent years. To learn more about EUDA Health Holdings call Wei Chen at 65 6327 1110 or check out https://www.euda.com.EUDA Health Quarterly Total Revenue |
|
EUDA Health Holdings Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. EUDA Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding EUDA Health Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
EUDA Health Holdings generated a negative expected return over the last 90 days | |
EUDA Health Holdings has high historical volatility and very poor performance | |
EUDA Health Holdings has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 4.01 M. Net Loss for the year was (17.6 M) with profit before overhead, payroll, taxes, and interest of 762.15 K. | |
EUDA Health generates negative cash flow from operations | |
About 50.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Mangoceuticals establishes 6 percent Series B convertible preferred stock - Investing.com |
EUDA Health Holdings Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EUDA Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
30th of October 2023 Upcoming Quarterly Report | View | |
30th of June 2023 Next Fiscal Quarter End | View |
EUDA Health Environmental, Social, and Governance (ESG) Scores
EUDA Health's ESG score is a quantitative measure that evaluates EUDA Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of EUDA Health's operations that may have significant financial implications and affect EUDA Health's stock price as well as guide investors towards more socially responsible investments.
EUDA Health Thematic Classifications
In addition to having EUDA Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
EUDA Stock Institutional Investors
Shares | Hudson Bay Capital Management Lp | 2025-03-31 | 800 K | Ubs Group Ag | 2025-03-31 | 19.6 K | Geode Capital Management, Llc | 2025-03-31 | 16 K | Xtx Topco Ltd | 2025-03-31 | 0.0 | Walleye Trading Advisors, Llc | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 0.0 |
EUDA Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 117.23 M.EUDA Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (11.03) | (10.48) | |
Return On Capital Employed | 7.19 | 7.55 | |
Return On Assets | (8.88) | (8.43) | |
Return On Equity | 6.02 | 6.32 |
Management Efficiency
EUDA Health Holdings has return on total asset (ROA) of (1.0719) % which means that it has lost $1.0719 on every $100 spent on assets. This is way below average. EUDA Health's management efficiency ratios could be used to measure how well EUDA Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, EUDA Health's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Equity is expected to grow to 6.32, whereas Return On Tangible Assets are projected to grow to (10.48). At present, EUDA Health's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 295.4 K, whereas Total Assets are forecasted to decline to about 1.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.08) | (0.08) | |
Tangible Book Value Per Share | (0.09) | (0.09) | |
Enterprise Value Over EBITDA | (8.39) | (7.97) | |
Price Book Value Ratio | (56.83) | (53.99) | |
Enterprise Value Multiple | (8.39) | (7.97) | |
Price Fair Value | (56.83) | (53.99) | |
Enterprise Value | 48.5 M | 62.8 M |
Management at EUDA Health Holdings focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 21st of July, EUDA Health shows the Standard Deviation of 3.55, mean deviation of 2.83, and Variance of 12.63. EUDA Health Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.EUDA Health Holdings Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of EUDA Health for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out EUDA Health Holdings short-term fluctuations and highlight longer-term trends or cycles.
EUDA Health Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EUDA Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on EUDA Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EUDA Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
8i Holdings 2 Pte Ltd over three weeks ago Disposition of tradable shares by 8i Holdings 2 Pte Ltd of EUDA Health subject to Rule 16b-3 | ||
Liew Kwong Yeow over three months ago Disposition of tradable shares by Liew Kwong Yeow of EUDA Health subject to Rule 16b-3 | ||
Tan Meng Dong James over a year ago EUDA Health exotic insider transaction detected | ||
Wei Chen over a year ago Acquisition or disposition of EUDA Health securities by Wei Chen | ||
Wong Kongyew over a year ago EUDA Health exotic insider transaction detected | ||
Wei Chen over a year ago EUDA Health exotic insider transaction detected | ||
Rajpal Ajay over a year ago EUDA Health exotic insider transaction detected |
EUDA Health Outstanding Bonds
EUDA Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EUDA Health Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EUDA bonds can be classified according to their maturity, which is the date when EUDA Health Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
EUDA Health Predictive Daily Indicators
EUDA Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EUDA Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
EUDA Health Forecast Models
EUDA Health's time-series forecasting models are one of many EUDA Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EUDA Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About EUDA Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how EUDA Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EUDA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EUDA Health. By using and applying EUDA Stock analysis, traders can create a robust methodology for identifying EUDA entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (4.40) | (4.18) | |
Operating Profit Margin | (4.32) | (4.11) | |
Net Loss | (3.83) | (4.02) | |
Gross Profit Margin | 0.19 | 0.35 |
Current EUDA Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EUDA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EUDA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
6.0 | Strong Buy | 1 | Odds |
Most EUDA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EUDA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of EUDA Health Holdings, talking to its executives and customers, or listening to EUDA conference calls.
EUDA Stock Analysis Indicators
EUDA Health Holdings stock analysis indicators help investors evaluate how EUDA Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EUDA Health shares will generate the highest return on investment. By understating and applying EUDA Health stock analysis, traders can identify EUDA Health position entry and exit signals to maximize returns.
Begin Period Cash Flow | 197.6 K | |
Common Stock Shares Outstanding | 32.5 M | |
Total Stockholder Equity | -2.6 M | |
Total Cashflows From Investing Activities | -147.8 K | |
Tax Provision | -4379.00 | |
Property Plant And Equipment Net | 316.3 K | |
Cash And Short Term Investments | 237.6 K | |
Cash | 237.6 K | |
Accounts Payable | 25.9 K | |
Net Debt | 1 M | |
50 Day M A | 3.5584 | |
Total Current Liabilities | 4.1 M | |
Other Operating Expenses | 21.3 M | |
Non Current Assets Total | 967.3 K | |
Non Currrent Assets Other | 281.4 K |
Complementary Tools for EUDA Stock analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |